Researchers investigate Cortisol's role in rare fat disorder
NCT ID NCT04845165
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the body processes cortisol in people with a rare genetic condition called familial partial lipodystrophy type 2 (FPL2). The goal was to see if increased activity of a certain enzyme (11β-HSD1) contributes to the severe metabolic problems seen in this disease. Researchers measured cortisol-related substances in urine and checked enzyme activity in fat tissue from 25 participants. The findings may help understand the disease better but do not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAMILIAL PARTIAL LIPODYSTROPHY TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hop Claude Huriez
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.